Nivolumab plus ipilimumab in hepatocellular carcinoma. Vithayathil M, Sharma R. Lancet 2025 May 7:S0140-6736(25)00417-9. doi: 10.1016/S0140-6736(25)00417.

Read + Share

Amedeo Smart

Independent Medical Education

Vithayathil M, Sharma R. Nivolumab plus ipilimumab in hepatocellular carcinoma. Lancet 2025 May 7:S0140-6736(25)00417-9. doi: 10.1016/S0140-6736(25)00417.
PMID: 40349715